S&P 500 Futures
(0.11%) 5 333.00 points

Dow Jones Futures
(0.02%) 40 146 points

Nasdaq Futures
(0.18%) 18 669 points

Oil
(-0.26%) $79.85

Gas
(0.69%) $2.64

Gold
(0.98%) $2 441.20

Silver
(2.59%) $32.07

Platinum
(-0.05%) $1 089.50

USD/EUR
(-0.01%) $0.920

USD/NOK
(-0.06%) $10.67

USD/GBP
(0.01%) $0.787

USD/RUB
(-0.61%) $90.42

Realtime updates for Neogenomics Inc [NEO]

Exchange: NASDAQ Sector: Healthcare Industry: Diagnostics & Research

BUY

50.00%
return -0.35%

SELL

75.00%
return -5.21%

Last Updated17 May 2024 @ 16:00

25% discount on Stockinvest.us - Use code: Podcast

-1.27% $ 14.80

SELL 137634 min ago

@ $14.92

Issued: 14 Feb 2024 @ 15:55

Return: -0.80%

Previous signal: Feb 14 - 14:11

Previous signal: Buy

Return: 1.53 %

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments...

Stats
Today's Volume	639 983
Average Volume	884 708
Market Cap	1.89B
EPS	$0 ( 2024-05-13 )
Next earnings date	( $0 ) 2024-08-13
Last Dividend	$0.400 ( 2020-12-17 )
Next Dividend	$0 ( N/A )
P/E	-22.42
ATR14	$0.0120 (0.08%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-15	Olivo Alicia C	Sell	1 049	Common Stock
2024-05-11	Smith Christopher M	Buy	48 063	Common Stock
2024-05-11	Smith Christopher M	Buy	48 063	Common Stock
2024-05-11	Smith Christopher M	Sell	18 913	Common Stock
2024-05-11	Smith Christopher M	Sell	48 063	Restricted Stock Unit

INSIDER POWER
84.41
Last 97 transactions
Buy: 2 701 923 \| Sell: 199 953

Volume Correlation

Long: 0.58 (weak)

Short: 0.42 (neutral)

Signal:(75.783) Neutral

Neogenomics Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Neogenomics Inc Correlation - Currency/Commodity

0.31
( neutral )

-0.22
( neutral )

0.00
( neutral )

0.76
( moderate )

-0.07
( neutral )

-0.86
( strong negative )

Neogenomics Inc Financials

Annual	2023
Revenue:	$591.64M
Gross Profit:	$244.60M (41.34 %)
EPS:	$-0.700

FY	2023
Revenue:	$591.64M
Gross Profit:	$244.60M (41.34 %)
EPS:	$-0.700

FY	2022
Revenue:	$509.73M
Gross Profit:	$187.90M (36.86 %)
EPS:	$-1.160

FY	2021
Revenue:	$484.33M
Gross Profit:	$187.06M (38.62 %)
EPS:	$-0.0700

Financial Reports:

No articles found.

Neogenomics Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Neogenomics Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 3.97 - low (31.86%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$0.400	2020-12-17
Last Dividend	$0.400	2020-12-17
Next Dividend	$0	N/A
Payout Date	2020-12-30
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$0.400	--
Avg. Dividend % Per Year	0.09%	--
Score	0.35	--
Div. Sustainability Score	3.97
Div.Growth Potential Score	0
Div. Directional Score	1.026	--

Next Divdend (Est)
(2024-05-20)

$0 Estimate 0.00 %

Dividend Stability

0.02 Very Bad

Dividend Score

0.35

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2020	$0.400	1.38%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
OXLC	Dividend Diamond	2023-12-14	Monthly	14	10.00%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
OXSQ	Dividend Royal	2023-12-14	Monthly	21	9.10%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
HRZN	Dividend Royal	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.138	1.500	-2.76	-4.14	[0 - 0.5]
returnOnAssetsTTM	-0.0514	1.200	-1.712	-2.05	[0 - 0.3]
returnOnEquityTTM	-0.0894	1.500	-2.10	-3.16	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	7.48	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	6.87	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	4.33	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.331	-1.500	4.48	-6.72	[0 - 0.6]
interestCoverageTTM	50.47	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	-0.120	2.00	-0.0401	-0.0802	[0 - 30]
freeCashFlowPerShareTTM	-0.314	2.00	-0.157	-0.314	[0 - 20]
debtEquityRatioTTM	0.588	-1.500	7.65	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.412	1.000	6.46	6.46	[0.2 - 0.8]
operatingProfitMarginTTM	-0.165	1.000	-5.30	-5.30	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.0279	1.000	-1.266	-1.266	[0.2 - 2]
assetTurnoverTTM	0.372	0.800	-0.851	-0.681	[0.5 - 2]
Total Score				3.97

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-22.16	1.000	-2.34	0	[1 - 100]
returnOnEquityTTM	-0.0894	2.50	-1.353	-3.16	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.314	2.00	-0.105	-0.314	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.120	2.00	-0.0401	-0.0802	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-2.27	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.0249	1.000	-3.12	0	[0.1 - 0.5]
Total Score				-1.913

Neogenomics Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Neogenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. The company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited. The company was founded in 2001 and is headquartered in Fort Myers, Florida.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.